Evaluation of protection against Chlamydophila abortus challenge after DNA immunization with the major outer-membrane protein-encoding gene in pregnant and non-pregnant mice

Journal of Medical Microbiology

Volumn 52, Issue 1, 2003, Pages 35-40

  Héchard, Céline ^a   Grépinet, Olivier ^a,b   Rodolakis, Annie ^a  

^a CEMAGREF   (France)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G2A; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; CHLAMYDOPHILA; CHLAMYDOPHILA ABORTUS; CONTROLLED STUDY; FEMALE; GENE; HUMORAL IMMUNITY; IMMUNIZATION; MOMP GENE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; SPLEEN; TH1 CELL;

ABORTION, SPONTANEOUS; ANIMALS; ANIMALS, OUTBRED STRAINS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CHLAMYDOPHILA; CHLAMYDOPHILA INFECTIONS; FEMALE; FETUS; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; MICE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SPLEEN; TIME FACTORS; VACCINES, DNA;

EID: 0037244773     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.04983-0     Document Type: Article

References (36)

1. Babiuk, L. A., Babiuk, S. L., Loehr, B. I. & van Drunnen Littel-van den Hurk, S. (2000). Nucleic acid vaccines: research tool or commercial reality. Vet Immunol Immunopathol 76, 1-23.
2. Barry, M. A. & Johnston, S. A. (1997). Biological features of genetic immunization. Vaccine 15, 788-791.
3. Buendia, A. J., Sànchez, J., Del Rio, L., Garces, B., Gallego, M. C., Caro, M. R., Bernabe, A. & Salinas, J. (1999). Differences in the immune response against ruminant chlamydial strains in a murine model. Vet Res 30, 495-507.
4. Buxton, D. (1986). Potential danger to pregnant women of Chlamydia psittaci from sheep. Vet Rec 118, 510-511.
5. Buzoni-Gatel, D., Bernard, F., Andersen, A. & Rodolakis, A. (1990). Protective effect of polyclonal and monoclonal antibodies against abortion in mice infected by Chlamydia psittaci. Vaccine 8, 342-346.
6. Caldwell, H. D., Kromhout, J. & Schachter, J. (1981). Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31, 1161-1176.
7. Davis, H. L., Whalen, R. G. & Demeneix, B. A. (1993). Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum Gene Ther 4, 151-159.
8. De Sa, C. (1996). The major outer-membrane protein of Chlamydia: structure and functions. Vet Res 27, 317-331 (in French).
9. De Sa, C., Souriau, A., Bernard, F., Salinas, J. & Rodolakis, A. (1995). An oligomer of the major outer membrane protein of Chlamydia psittaci is recognized by monoclonal antibodies which protect mice from abortion. Infect Immun 63, 4912-4916.
10. Dong-Ji, Z., Yang, X., Shen, C., Lu, H., Murdin, A. & Brunham, R. C. (2000). Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses. Infect Immun 68, 3074-3078.
11. Donnelly, J. J., Ulmer, J. B., Shiver, J. W. & Liu, M. A. (1997). DNA vaccines. Annu Rev Immunol 15, 617-648.
12. Faye, P., Charton, A., Mage, C., Bernard, C. & Le Layec, C. (1972). Propriétés hémagglutinantes du 'virus' de l'avortement enzootique des petits ruminants (souches de 'Rakeia' d'origine ovine et caprine). Note préliminaire. Bull Acad Vét Fr 45, 169-173.
13. Gurunathan, S., Klinman, D. M. & Seder, R. A. (2000). DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 18, 927-974.
14. Héchard, C., Grépinet, O. & Rodolakis, A. (2002). Protection evaluation against Chlamydophila abortus challenge by DNA vaccination with a dnaK-encoding plasmid in pregnant and non-pregnant mice. Vet Res 33, 313-326.
15. Igietseme, J. U. & Murdin, A. (2000). Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes. Infect Immun 68, 6798-6806.
16. Krieg, A. M. (2000). Immune effects and mechanisms of action of CpG motifs. Vaccine 19, 618-622.
17. Murdin, A. D., Su, H., Klein, M. H. & Caldwell, H. D. (1995). Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies. Infect Immun 63, 1116-1121.
18. Pal, S., Theodor, I., Peterson, E. M. & de la Maza, L. M. (1997). Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Infect Immun 65, 3361-3369.
19. Pal, S., Barnhart, K. M., Wei, Q., Abai, A. M., Peterson, E. M. & de la Maza, L. M. (1999). Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge. Vaccine 17, 459-465.
20. Papp, J. R. & Shewen, P. E. (1996). Localization of chronic Chlamydia psittaci infection in the reproductive tract of sheep. J Infect Dis 174, 1296-1302.
21. Penttilä, T., Vuola, J. M., Puurula, V., Anttila, M., Sarvas, M., Rautonen, N., Makela, P. H. & Puolakkainen, M. (2000). Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2). Vaccine 19, 1256-1265.
22. Rodolakis, A. (1983). In vitro and in vivo properties of chemically induced temperature-sensitive mutants of Chlamydia psittaci var. ovis: screening in a murine model. Infect Immun 42, 525-530.
23. Rodolakis, A. & Chancerelle, L. (1977). Plaque assay for Chlamydia psittaci in tissue samples. Ann Microbiol (Paris) 128B, 81-85 (in French).
24. Rodolakis, A. & Souriau, A. (1979). Clinical evaluation of a commercial vaccine against chlamydial abortion of ewes. Ann Rech Vét 10, 41-48.
25. Rodolakis, A., Bernard, F. & Lantier, F. (1989). Mouse models for evaluation of virulence of Chlamydia psittaci isolated from ruminants. Res Vet Sci 46, 34-39.
26. Schachter, J., Banks, J., Sugg, N., Sung, M., Storz, J. & Meyer, K. F. (1974). Serotyping of Chlamydia. I. Isolates of ovine origin. Infect Immun 9, 92-94.
27. Scheerlinck, J. P., Casey, G., McWaters, P., Kelly, J., Woollard, D., Lightowlers, M. W., Tennent, J. M. & Chaplin, P. J. (2001). The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine 19, 4053-4060.
28. Song, M. K., Lee, S. W., Suh, Y. S., Lee, K. J. & Sung, Y. C. (2000). Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice. J Virol 74, 2920-2925.
29. Strugnell, R. A., Drew, D., Mercieca, J., DiNatale, S., Firez, N., Dunston, S. J., Simmons, C. P. & Vadolas, J. (1997). DNA vaccines for bacterial infections. Immunol Cell Biol 75, 364-369.
30. Su, H., Parnell, M. & Caldwell, H. D. (1995). Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a routine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 13, 1023-1032.
31. Tan, T. W., Herring, A. J., Anderson, I. E. & Jones, G. E. (1990). Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein. Infect Immun 58, 3101-3108.
32. Tuffrey, M., Alexander, F., Conlan, W., Woods, C. & Ward, M. (1992). Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein. J Gen Microbiol 138, 1707-1715.
33. van Oirschot, J. T., Kaashoek, M. J. & Rijsewijk, F. A. (1996). Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Vet Microbiol 53, 43-54.
34. Vanrompay, D., Cox, E., Vandenbussche, F., Volckaert, G. & Goddeeris, B. (1999). Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunizations. Vaccine 17, 2628-2635.
35. Wyllie, S., Longbottom, D., Herring, A. J. & Ashley, R. H. (1999). Single channel analysis of recombinant major outer membrane protein porins from Chlamydia psittaci and Chlamydia pneumoniae: FEBS Lett 445, 192-196.
36. Zhang, D.-J., Yang, X., Berry, J., Shen, C., McClarty, G. & Brunham, R. C. (1997). DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 176, 1035-1040.